Published on 4 Feb 2023 on Simply Wall St. via Yahoo Finance
Immuneering Corporation (NASDAQ:IMRX) insiders, who hold 31% of the firm would be disappointed by...
To get a sense of who is truly in control of Immuneering Corporation (NASDAQ:IMRX), it is important to understand the ownership structure of the business. We can see that individual insiders own the lion's share in the company with 31% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
And following last week's 11% decline in share price, insiders suffered the most losses.